Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0848771 (
neurological disability
)
928
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thirty cases of subarachnoid haemorrhage (SAH), who underwent early aneurysm clipping, were studied to clarify the significance of a critical increase of blood flow velocities in correlation to
neurological disability
and cerebral blood flow. Three different groups of patients could be distinguished: 57% (17) of the cases showed increased TCD-values at the affected side corresponding to secondary neurological deficits (Vasospasm-group). The
CBF
-results pointed out a side difference according to the flow acceleration. In 7 patients (23%) we detected a similar side difference in blood flow velocity, but no secondary deficit appeared. The corresponding
CBF
-measurements showed risen values with no side difference (Hyperaemia-group). The third group of patients (20% i.e.6 cases) developed neurological deficits and corresponding side difference in
CBF
-measurements, but the transcranial Doppler sonography could not detect a significant side difference and even showed normal values (Blind-TCD-group). Critical increased blood flow velocities after SAH without secondary neurological deficits does not indicate vasospasm but hyperaemia.
...
PMID:Critical increase of blood flow velocities after subarachnoid haemorrhage: vasospasm versus hyperaemia. 877 72